CDEK
← All organizations
Hospira

Hospira

For profitContributed to NME

Also known as: BH | HOSPIRA | HOSPIRA INC | HOSPIRA WORLDWIDE | Medical Director, Hospira

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 1, 2005

First marketed drug

Jan 1, 2004

Last known activity

Dec 23, 2014

Acquired by Pfizer on Jan 1, 2015

Timeline

1970s

  1. Dec 18, 1970

    floxuridine— NDA Organization

1980s

  1. Dec 14, 1984

    theophylline— NDA Secondary Org

  2. Apr 3, 1987

    trimethobenzamide— Marketing Organization

2000s

  1. Jan 1, 2004

    Hospira— Founded

  2. Jan 1, 2009

    Orchid Pharma— Acquired

2010s

  1. Jan 1, 2010

    Javelin Pharmaceuticals— Acquired

  2. Jan 1, 2010

    Theradoc— Acquired

  3. Jan 1, 2015

    Pfizer— Acquired By

Drugs by trial phase (17 distinct, 44 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (1 own, 4 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (215)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (28)

Details

Founded
Lake Forest, IL, US Jan 1, 2004
Last known activity
Dec 23, 2014

Designations held

  • Orphan drug
  • Priority review

Notes

Acquired by Pfizer